Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
Conditions: Pancreatic Cancer Interventions: Drug: Irinotecan liposome II combination therapy regimen Sponsors: Peking Union Medical College Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | China Health | Hospitals | Pancreas | Pancreatic Cancer | Research | Study